2019 Chinese Clinical Practice Guidelines for the Prevention of Mother-to-child Transmission of Hepatitis B Virus
Open Access
- 2 November 2020
- journal article
- review article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 8 (4), 1-10
- https://doi.org/10.14218/jcth.2020.00070
Abstract
To develop the evidence-based guidelines for managing mother-to-child transmission of hepatitis B virus in China, a multidisciplinary guideline development group was established. Clinical questions were identified from two rounds of surveys on the concerns of first-line clinicians. We conducted a comprehensive search and review of the literature. A grading of recommendations’ assessment, development, and evaluation system was adopted to rate the quality of evidence and the strength of recommendations. Recommendations were formulated based on the evidence, overall balance of benefits and harms (at individual and population levels), patient/health worker values and preferences, resources available, cost-effectiveness, and feasibility. Eventually, recommendations related to 13 main clinical concerns were developed, covering diagnostic criteria, treatment indications, antiviral therapy choice, timing to initiate and discontinue treatment, immunoprophylaxis strategy at birth, and how to deal with special situations, such as unintended pregnancy, assisted reproduction, and breastfeeding. The guidelines are intended to serve as guidance for clinicians and patients, to optimize the management of majority of pregnant women who are positive for hepatitis B surface antigen. Guideline registration: International Practice Guide Registration Platform (IPGRP-2018CN040).Keywords
This publication has 53 references indexed in Scilit:
- Dynamic changes of HBV markers and HBV DNA load in infants born to HBsAg(+) mothers: can positivity of HBsAg or HBV DNA at birth be an indicator for HBV infection of infants?BMC Infectious Diseases, 2013
- Hepatitis B virus infection in clustering of infection in families with unfavorable prognoses in northwest ChinaJournal of Medical Virology, 2013
- The efficacy and safety of antiviral therapy with lamivudine to stop the vertical transmission of hepatitis B virusEuropean Journal of Clinical Microbiology & Infectious Diseases, 2012
- Virologic factors associated with failure to passive–active immunoprophylaxis in infants born to HBsAg‐positive mothersJournal of Viral Hepatitis, 2011
- AGREE II: Advancing guideline development, reporting, and evaluation in health carePreventive Medicine, 2010
- AGREE II: advancing guideline development, reporting and evaluation in health careCMAJ : Canadian Medical Association Journal, 2010
- 2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis BGastroenterology, 2009
- Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusiveBMJ, 2008
- ErrataBirth Defects Research Part A: Clinical and Molecular Teratology, 2008
- Infant of 22 months of age with no anomalies born from a HCV- and HIV-infected mother under treatment with pegylated interferon, ribavirin and antiretroviral therapy during the first 16 weeks of pregnancyReproductive Toxicology, 2007